PUBLISHER: The Business Research Company | PRODUCT CODE: 1945348
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945348
Implantable collamer lenses (ICLs), also known as implantable contact lenses, are a type of refractive lens implant designed to treat various eye conditions. They function similarly to contact lenses, but instead of being worn on the surface of the eye, they are surgically inserted in front of the natural lens and behind the iris, which is the colored part of the eye.
The primary types of implantable collamer lenses are the Visian implantable collamer lens (ICL) and the EVO implantable collamer lens (ICL). The Visian ICL is a phakic intraocular lens used to correct vision problems such as myopia, hyperopia, and astigmatism, providing a reversible and biocompatible alternative to LASIK surgery. These lenses incorporate technologies such as laser-assisted and traditional techniques. They are mainly used for treating myopia, hyperopia, and astigmatism and are utilized by various end users, including ophthalmic clinics, hospitals, ambulatory surgical centers, and other healthcare facilities.
Tariffs are influencing the implantable collamer lens market by increasing costs of imported biocompatible polymers, precision lens components, surgical instruments, and ophthalmic manufacturing equipment. Ophthalmic clinics and hospitals in North America and Europe are most affected due to dependence on imported lens systems, while Asia-Pacific faces cost pressures on lens production and export activities. These tariffs are contributing to higher procedure costs and slower adoption in price-sensitive markets. At the same time, they are encouraging regional manufacturing, localized lens assembly, and innovation in cost-optimized ophthalmic implant solutions.
The implantable collamer lens market research report is one of a series of new reports from The Business Research Company that provides implantable collamer lens market statistics, including implantable collamer lens industry global market size, regional shares, competitors with a implantable collamer lens market share, detailed implantable collamer lens market segments, market trends and opportunities, and any further data you may need to thrive in the implantable collamer lens industry. This implantable collamer lens market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The implantable collamer lens market size has grown strongly in recent years. It will grow from $20.77 billion in 2025 to $22.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing prevalence of refractive vision disorders, rising demand for surgical vision correction, technological advancements in ophthalmic implants, growing acceptance of icl procedures, expansion of specialized ophthalmic clinics.
The implantable collamer lens market size is expected to see strong growth in the next few years. It will grow to $28.74 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing adoption of premium vision correction solutions, rising focus on minimally invasive ophthalmic surgeries, expansion of elective eye care procedures, growing investments in advanced ophthalmology technologies, increasing patient awareness of icl benefits. Major trends in the forecast period include increasing adoption of evo implantable collamer lenses, rising use of laser-assisted implantation techniques, growing demand for reversible vision correction solutions, expansion of customized lens designs, enhanced focus on long-term visual stability.
The rising prevalence of vision disorders is expected to drive growth in the implantable collamer lens (ICL) market in the coming years. Vision disorders encompass conditions that impair clear sight, often characterized by a gradual decline in visual acuity and overall eye health. Their prevalence is increasing globally due to factors such as an aging population, prolonged screen time, and the growing incidence of conditions like myopia and age-related macular degeneration. Implantable collamer lenses provide an effective solution for correcting vision disorders such as myopia, hyperopia, and astigmatism, offering a safe and reversible alternative to traditional refractive surgeries like LASIK. For example, in August 2023, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that over 2.2 billion people worldwide experience near or distance vision impairment, with 1 billion of these cases being preventable or unaddressed. Therefore, the increasing prevalence of vision disorders is driving growth in the implantable collamer lens market.
Major players in the implantable collamer lens market are emphasizing technological innovations, such as biocompatible, minimally invasive lens implants that correct a wide range of refractive errors without removing corneal tissue, to enhance patient outcomes and reduce reliance on glasses and contact lenses. Biocompatible minimally invasive implantable lenses provide safe, reversible vision correction by working with the eye's natural anatomy, allowing for quick procedures and high patient satisfaction. For example, in March 2024, STAAR Surgical Company, a US-based ophthalmic medical device company, reported that over three million EVO ICL lenses have been implanted worldwide. The EVO ICL corrects myopia, with or without astigmatism, and presbyopia through a 20-30 minute procedure that positions the lens between the iris and the natural crystalline lens. This biocompatible, removable lens offers a next-generation alternative to glasses and contact lenses, helping millions of patients achieve improved vision safely and effectively.
In May 2025, Alcon, a Switzerland-based eye care company, acquired STAAR Surgical for approximately $1.5 billion. Through this acquisition, Alcon aims to expand its surgical vision correction portfolio, complementing its laser vision correction offerings and providing solutions for patients with moderate to high myopia. STAAR Surgical, a US-based medical device company, specializes in implantable collamer lenses.
Major companies operating in the implantable collamer lens market are STAAR Surgical Company, Care Group Sight Solutions (IPCL), Ophtec (Artisan Phakic IOLs), Rayner Surgical, Hoya Surgical Optics, Alcon Inc., Johnson & Johnson Vision/Abbott Medical Optics, Bausch + Lomb, Carl Zeiss Meditec AG, Nidek Co. Ltd., Lenstec Inc., SIFI S.p.A., Optimedical, Eyeonics (now part of Santen)*, Physiol LLC, Microlens Tech Co. Ltd., HumanOptics AG, Ocular Instruments Inc., Aaren Scientific LLC, Visiogen Inc.
North America was the largest region in the implantable collamer lens market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the implantable collamer lens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The implantable collamer lens (ICL) market consists of sales of lenses, ICL delivery systems, surgical equipment, and preoperative diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Implantable Collamer Lens Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses implantable collamer lens market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for implantable collamer lens ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable collamer lens market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.